Imperial Valley News Center
FinTech finds a home in the FTC Business Center
- Details
- Written by IVN
Washington, DC - The term “FinTech” covers a lot of topics central to the FTC’s consumer protection mission – lending, payment systems, data security, privacy, and truth in advertising, to name just a few. So where can businesses go for resources on how established consumer protection standards apply in this emerging marketplace? FinTech-related materials have a new home in the Business Center: a dedicated FinTech page.
Imperial County Board of Supervisors Announce Off-Site Meeting Schedule
- Details
- Written by Imperial Valley News
El Centro, California - In an effort to reach all communities within Imperial County, the Board of Supervisors have announced a series of off-site meetings in each supervisorial district throughout the year. The meetings are open to the public and residents from all districts are encouraged to attend.
FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies
- Details
- Written by IVN
Washington, DC - Today, the U.S. Food and Drug Administration authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies in human blood. The ZIKV Detect 2.0 IgM Capture ELISA is the first Zika diagnostic test the FDA has allowed to be marketed in the U.S.; previously, tests for detecting Zika virus IgM antibodies—including the ZIKV Detect 2.0 IgM Capture ELISA—had been authorized only for emergency use under the FDA’s Emergency Use Authorization (EUA) authority.
FDA alerts hospitals, laboratories and health care professionals about recall of Beckman Coulter blood test analyzers
- Details
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration is alerting hospitals, laboratories and providers of a Class 1 recall of Beckman Coulter DxH 800, DxH 600 and DxH 900 hematology analyzers—devices that run blood tests to help providers diagnose diseases and conditions such as anemia (low red blood cell or hemoglobin count), infections, blood clotting problems, blood cancers and immune system disorders. This is an update to an urgent medical device correction letter first issued by the company in 2018, after the company received complaints of inaccurate blood platelet counts.
Rule Providing Model Forms and Disclosures To Facilitate Compliance with the Fair Credit Reporting Act Amended
- Details
- Written by FTC
Washington, DC - The Federal Trade Commission has approved publication of a Federal Register notice announcing the rescission of several model forms and disclosures under the Fair Credit Reporting Act (FCRA).
FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea
- Details
- Written by Stephanie Caccomo
Washington, DC - Today, the U.S. Food and Drug Administration cleared for marketing two tests that can detect the presence of the bacteria Chlamydia trachomatis and Neisseria gonorrhoeae, which cause the sexually-transmitted infections, respectively, chlamydia and gonorrhea, through diagnostic testing of extragenital specimens. The Aptima Combo 2 Assay and the Xpert CT/NG are the first devices cleared for extragenital diagnostic testing of these infections via the throat and rectum. These tests were previously only cleared for testing urine, vaginal and endocervical samples.
Page 4 of 3036
